-
EP4199927
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4199927
| EP4199927 - METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 14.06.2024 Database last updated on 12.10.2024 | |
| Former | Request for examination was made Status updated on 26.05.2023 | ||
| Former | The international publication has been made Status updated on 25.02.2022 | ||
| Former | unknown Status updated on 17.09.2021 | Most recent event Tooltip | 20.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 / US | [2023/26] | Inventor(s) | 01 /
BELACHEW, Shibeshih Cambridge, MA 02142 / US | 02 /
CAHIR-MCFARLAND, Ellen Cambridge, MA 02142 / US | 03 /
SHAO, Zhaohui Cambridge, MA 02142 / US | 04 /
TSAI, Hui-Hsin Cambridge, MA 02142 / US | 05 /
WEI, Ru Cambridge, MA 02142 / US | [2023/26] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2023/26] | Application number, filing date | 21766792.2 | 19.08.2021 | [2023/26] | WO2021US46589 | Priority number, date | US202063067727P | 19.08.2020 Original published format: US 202063067727 P | [2023/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022040369 | Date: | 24.02.2022 | Language: | EN | [2022/08] | Type: | A1 Application with search report | No.: | EP4199927 | Date: | 28.06.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.02.2022 takes the place of the publication of the European patent application. | [2023/26] | Search report(s) | International search report - published on: | EP | 24.02.2022 | Classification | IPC: | A61K31/451, A61K45/06, A61K38/02, A61K38/21, A61P25/28, G01N33/00 | [2023/26] | CPC: |
A61K31/451 (EP);
A61K31/445 (US);
A61K38/02 (EP);
A61K38/215 (EP);
A61K45/06 (EP,US);
A61P25/28 (EP);
| C-Set: |
A61K31/451, A61K2300/00 (EP);
A61K38/02, A61K2300/00 (EP);
A61K38/215, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/26] | Extension states | BA | 17.03.2023 | ME | 17.03.2023 | Validation states | KH | 17.03.2023 | MA | 17.03.2023 | MD | 17.03.2023 | TN | 17.03.2023 | Title | German: | VERFAHREN ZUR BEHANDLUNG VON REMITTIERENDER MULTIPLER SKLEROSE | [2023/26] | English: | METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS | [2023/26] | French: | MÉTHODES DE TRAITEMENT DE LA SCLÉROSE EN PLAQUES RÉMITTENTE | [2023/26] | Entry into regional phase | 17.03.2023 | National basic fee paid | 17.03.2023 | Designation fee(s) paid | 17.03.2023 | Examination fee paid | Examination procedure | 17.03.2023 | Examination requested [2023/26] | 17.03.2023 | Date on which the examining division has become responsible | 09.10.2023 | Amendment by applicant (claims and/or description) | 25.06.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 17.03.2023 | Renewal fee patent year 03 | 20.08.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2012109108 (BIOGEN IDEC INC [US], et al); | [A]WO2014018891 (BIOGEN IDEC INC [US]); | by applicant | US9340527 |